Related Experiment Videos
Monoclonal antibodies against noxiustoxin
P Hérion1, G Gurrola-Briones, M Del Rocío Sánchez
1Departamento de Immunología, Universidad Nacional Autónoma de México, Mexico.
Hybridoma
|June 1, 1995
Summary
Monoclonal antibodies (MAbs) were developed against noxiustoxin, a scorpion venom peptide affecting potassium channels. These MAbs inhibited toxin binding, suggesting potential for studying toxin structure-function and identifying related toxins.
Area of Science:
- Neuroscience
- Immunology
- Biochemistry
Background:
- Noxiustoxin, a peptide from Centruroides noxius scorpion venom, targets voltage-dependent K+ channels.
- Understanding noxiustoxin's interaction with its targets is crucial for neuropharmacology.
Purpose of the Study:
- To isolate and characterize monoclonal antibodies (MAbs) against noxiustoxin.
- To utilize these MAbs for structure-function relationship studies of noxiustoxin.
- To investigate potential cross-reactivity with other scorpion venom components.
Main Methods:
- Isolation and characterization of six hybridoma clones producing MAbs against noxiustoxin.
- Epitope mapping to determine antibody binding sites on noxiustoxin.
- Assays to measure MAb inhibition of noxiustoxin binding to rat brain synaptosomal membranes.
- Cross-reactivity tests with venom from other Centruroides species.
Main Results:
- Six MAbs (BNTX4, -12, -14, -16, -18, -21) were successfully generated.
- MAbs bind to overlapping or proximal epitopes on noxiustoxin, preventing simultaneous binding.
- All MAbs demonstrated varying degrees of inhibition on noxiustoxin's receptor binding.
- Cross-reactivity was observed with venom from other Centruroides species.
Conclusions:
- Monoclonal antibodies provide valuable tools for studying noxiustoxin structure-function.
- The identified MAbs can be used to probe noxiustoxin-receptor interactions.
- Cross-reactivity suggests the presence of structurally similar noxiustoxin-like toxins in related scorpion species.